bibliographicCitation |
Melani A, Gianfriddo M, Vannucchi MG, Cipriani S, Baraldi PG, Giovannini MG, Pedata F. The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia. Brain Res. 2006 Feb 16;1073-1074():470–80. doi: 10.1016/j.brainres.2005.12.010. PMID: 16443200. |